Orthopedic imaging technology developer EOS Imaging reported 63% growth in revenues in the first half of the company's financial year as system shipments resumed after being interrupted by the COVID-19 outbreak.
For the first half, EOS posted sales of 9.8 million euros, up 63% compared with 6 million euros in the first half of 2019. The company cut its net loss roughly in half, to 4.9 million euros in the most recent period, compared with 10 million euros in the first half of 2019.
The company said it has seen a resumption of equipment purchasing following the COVID-19 outbreak, as well as the first installations of its new EOSedge orthopedic digital radiography system in the U.S. and Europe. Additionally, the company saw a 17% decline in operational expenses, the result of lower marketing expenses due to trade shows and other events canceled due to the pandemic.
